Huadong Medicine Co., Ltd (SHE:000963)

China flag China · Delayed Price · Currency is CNY
36.28
+0.39 (1.09%)
Feb 3, 2026, 3:04 PM CST
4.25%
Market Cap62.80B +9.4%
Revenue (ttm)43.09B +3.3%
Net Income3.70B +15.1%
EPS2.11 +14.8%
Shares Out1.75B
PE Ratio17.04
Forward PE17.27
Dividend0.93 (2.58%)
Ex-Dividend DateSep 18, 2025
Volume6,331,457
Average Volume11,530,227
Open36.61
Previous Close35.89
Day's Range35.81 - 36.61
52-Week Range32.98 - 47.36
Beta0.45
RSI26.46
Earnings DateApr 24, 2026

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ... [Read more]

Sector Healthcare
Founded 1993
Employees 18,265
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000963
Full Company Profile

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.

Financial Statements